Literature DB >> 12003092

Comparison of the effects of antenatal magnesium sulphate and ritodrine exposure on circulatory adaptation in preterm infants.

T H Rantone1, J U Grönlund, J O Jalonen, U U Ekblad, P O Kääpä, P O Kero, I A T Välimäki.   

Abstract

We examined the effects of maternal magnesium sulphate (MgSO4) and ritodrine treatments on the autonomic cardiovascular control in preterm neonates with respiratory distress syndrome during the first 2 days of life. Serial measurements of heart rate (HR), blood pressure (BP) and respirogram were performed during the first 2 days of life in 28 preterm infants below 33 weeks of gestation with antenatal exposure to MgSO4 (n = 13) or ritodrine (n = 15), and in 12 nonexposed preterm controls. Spectral analysis was used for the quantification of HR and BP variability. Although antenatal MgSO4 exposure had no effect on HR or the systolic, diastolic or mean BP, it was associated with significant decreased beat-to-beat changes in BP. In contrast, ritodrine exposure had no consistent effects on the autonomic cardiovascular control during the first 2 days of life. Our data suggest that maternal MgSO4 treatment decreases the neonatal high frequency changes in BP. This early vascular stabilizing effect of antenatal MgSO4 exposure may contribute to a lowered risk of cerebral vascular catastrophes, in the vulnerable areas of the brain, among the preterm infants with respiratory distress syndrome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12003092     DOI: 10.1046/j.1475-097x.2002.00387.x

Source DB:  PubMed          Journal:  Clin Physiol Funct Imaging        ISSN: 1475-0961            Impact factor:   2.273


  7 in total

1.  Effect of Lomodex-MgSO(4) in the prevention of reperfusion injury following unilateral testicular torsion: an experimental study in rats.

Authors:  Prashant K Adivarekar; Sarita S Bhagwat; Vijaya Raghavan; A H Bandivdekar
Journal:  Pediatr Surg Int       Date:  2005-02-15       Impact factor: 1.827

2.  Effects of antenatal magnesium sulfate treatment for neonatal neuro-protection on cerebral oxygen kinetics.

Authors:  Michael J Stark; Nicolette A Hodyl; Chad C Andersen
Journal:  Pediatr Res       Date:  2015-05-18       Impact factor: 3.756

3.  Antenatal magnesium sulfate exposure and acute cardiorespiratory events in preterm infants.

Authors:  Lilia C De Jesus; Beena G Sood; Seetha Shankaran; Douglas Kendrick; Abhik Das; Edward F Bell; Barbara J Stoll; Abbot R Laptook; Michele C Walsh; Waldemar A Carlo; Pablo J Sanchez; Krisa P Van Meurs; Rebecca Bara; Ellen C Hale; Nancy S Newman; M Bethany Ball; Rosemary D Higgins
Journal:  Am J Obstet Gynecol       Date:  2014-07-18       Impact factor: 8.661

4.  Effect of Neuroprotective Magnesium Sulfate Treatment on Brain Transcription Response to Hypoxia Ischemia in Neonate Mice.

Authors:  Bérénice Le Dieu-Lugon; Nicolas Dupré; Céline Derambure; François Janin; Bruno J Gonzalez; Stéphane Marret; Arnaud Arabo; Philippe Leroux
Journal:  Int J Mol Sci       Date:  2021-04-20       Impact factor: 5.923

Review 5.  Neonatal heart rate variability: a contemporary scoping review of analysis methods and clinical applications.

Authors:  Samantha Latremouille; Justin Lam; Wissam Shalish; Guilherme Sant'Anna
Journal:  BMJ Open       Date:  2021-12-21       Impact factor: 2.692

6.  Magnesium sulphate at 30 to 34 weeks' gestational age: neuroprotection trial (MAGENTA)--study protocol.

Authors:  Caroline A Crowther; Philippa F Middleton; Dominic Wilkinson; Pat Ashwood; Ross Haslam
Journal:  BMC Pregnancy Childbirth       Date:  2013-04-09       Impact factor: 3.007

7.  Antenatal magnesium individual participant data international collaboration: assessing the benefits for babies using the best level of evidence (AMICABLE).

Authors: 
Journal:  Syst Rev       Date:  2012-03-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.